ImageneBio Inc

IMA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$24,779-$2,767-$8,619-$9,124
Dep. & Amort.$0$87$87$89
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$458$904$998
Change in WC-$13,339-$1,694-$3,271$1,537
Other Non-Cash$11,476$494$337$240
Operating Cash Flow-$26,642-$3,422-$10,562-$6,260
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions-$5,215$0$0$0
Inv. Purchases$21,699-$5,997-$17,187-$7,262
Inv. Sales/Matur.-$68,815$45,946$25,119$15,225
Other Inv. Act.$15,000-$15,000$0-$7,500
Investing Cash Flow-$37,331$24,949$7,932$463
Financing Activities
Debt Repay.$15,000$0$0$0
Stock Issued$65,837$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$54,631$0$0$0
Financing Cash Flow$135,468$0$0$0
Forex Effect-$26,623$0$0$0
Net Chg. in Cash$44,872$21,527-$2,630-$5,797
Supplemental Information
Beg. Cash$58,290$37,635$40,265$46,062
End Cash$103,162$59,162$37,635$40,265
Free Cash Flow-$26,642-$3,422-$10,562-$6,260